Floatz logo

VENLOR

Stage IA Breast Cancer

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Stage IA Breast Cancer cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2BB
Docosahexaenoic Acid
National Cancer Institute (NCI)
Phase 2B
Telapristone Acetate
Northwestern University
Phase 2B
Methylene Blue
University of Southern California
Phase 2CCC
AE-BROCCOLI
Roswell Park Cancer Institute
Early Phase 1CC

Same molecule, other indications

VENLOR is also rated in:

depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →
VenlafaxineDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →